The ‘innovation gap’ haunts Big Pharma, and the race is on for the next blockbusters

Listen to the article 7 min This audio is auto-generated. Please let us know if you have feedback. History often repeats itself, and the pharmaceutical industry’s current “innovation gap” is one they’ve seen before — the world’s largest companies find themselves in the precarious position of needing to make big new bets before their once … Read more

Laura Randa’s aim to break down mental healthcare barriers for disabled patients

Listen to the article 6 min This audio is auto-generated. Please let us know if you have feedback. Laura Randa calls her 20-year-old daughter, Lauren, a “rock star,” and rattles off Lauren’s many accomplishments without much prompting: She’s been a nationally competitive figure skater, was a National Merit finalist and is a student at University … Read more

Johnson & Johnson shareholders called on to end talc baby powder sales | Pharmaceuticals industry

Women’s health groups are calling on healthcare giant Johnson & Johnson’s largest shareholders to force the company to end all sales of its controversial talk-based baby powder and hire an independent firm to conduct a racial justice audit. The pressure comes after decades of independent science suggested a link between ovarian cancer and baby powder, … Read more

Mouse vs. machine: Using AI to solve the animal testing model in pharma

Listen to the article 7 min This audio is auto-generated. Please let us know if you have feedback. No more poison injections, induced tumors, forced obesity or other unspeakable cruelties. Mice everywhere would rejoice if they knew that artificial intelligence might someday take over their jobs in pharmaceutical testing, and that day is coming closer … Read more

Real-world data is making drug development more true to life

Listen to the article 7 min This audio is auto-generated. Please let us know if you have feedback. Real-world data (RWD) has long played a supporting role in the pharma industry, primarily acting as a monitor for post-approval drug safety. Now, drugmakers are looking to save time and money using the data in new, more … Read more

From the fringes to the forefront — the mRNA era has taken hold of pharma

Listen to the article 12 min This audio is auto-generated. Please let us know if you have feedback. The genetic technology mRNA has quickly come a long way in a short period of time. Its story dates back more than 70 years when researchers began assessing its therapeutic potential. Over the past two decades, several … Read more

How OliX Pharmaceuticals is riding the RNAi wave

Listen to the article 7 min This audio is auto-generated. Please let us know if you have feedback. Welcome to today’s Biotech Spotlight, a series featuring companies that are creating breakthrough technologies and products. Today, we’re looking at OliX Pharmaceuticals, which developed cell-penetrating asymmetric RNAi technology. Optional Caption Permission provided by Dong-ki Lee. In focus … Read more

Dispelling the 5 myths of biopharma brand planning

Many biopharma marketers have worked for more than one company during their career. One of the great benefits of doing this is that the marketer can see the ways different companies address common industry needs and processes. Take brand planning for example: Standard outputs include brand strategy, an operational plan, and a budget, yet the … Read more

US Chamber of Commerce Supports House and Senate Legislation Prohibiting Biden Administration from Negotiating Modifications to WTO TRIPS Agreement Without Congressional Authorization

By Donald Zuhn — Earlier this month, the US Chamber of Commerce sent a letter to members of Congress indicating that the Chamber “strongly supports” recent House and Senate legislation that the Chamber noted “would prohibit the Administration from negotiating or concluding any modifications to the World Trade Organization (WTO) Trade-Related Aspects of Intellectual Property … Read more